Graham Dempsey, Ph.D.

Graham Dempsey, Ph.D., joined Quiver Bioscience as a senior scientist at the company’s inception (formerly Q-State Biosciences) in 2014. Before assuming the Chief Scientific Officer role, Graham successfully led the development and rapid evolution of the company’s foundational technology platforms as well as its first small molecule and antisense oligonucleotide therapeutic programs. During his academic studies, Dr. Dempsey developed novel fluorescence-based imaging platforms for investigating biological systems and was on the team that developed the super-resolution imaging technique called stochastic optical reconstruction microscopy (STORM) that was subsequently commercialized by Nikon Instruments. In his role at Quiver, Graham directs the planning and execution of all scientific, medical, engineering and AI/machine learning activities at the company. He holds a B.A. in biochemistry and biophysics from the University of Pennsylvania and a Ph.D. in biophysics from Harvard University.